OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies
Zhenfeng Zhang, Stephan Urban
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 686-699
Open Access | Times Cited: 50
Zhenfeng Zhang, Stephan Urban
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 686-699
Open Access | Times Cited: 50
Showing 26-50 of 50 citing articles:
Hepatitis delta: Epidemiology to recent advances in therapeutic agents
Nehna Abdul Majeed, Benno Zehnder, Christopher Koh, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1306-1321
Closed Access | Times Cited: 4
Nehna Abdul Majeed, Benno Zehnder, Christopher Koh, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1306-1321
Closed Access | Times Cited: 4
Emerging anti‐HDV drugs and HBV cure strategies with anti‐HDV activity
Armando Andres Roca Suarez, Enkhtuul Batbold, Birke Bartosch, et al.
Liver International (2023) Vol. 43, Iss. S1, pp. 87-95
Closed Access | Times Cited: 4
Armando Andres Roca Suarez, Enkhtuul Batbold, Birke Bartosch, et al.
Liver International (2023) Vol. 43, Iss. S1, pp. 87-95
Closed Access | Times Cited: 4
Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity
Anne-Flore Legrand, Julie Lucifora, Benoît Lacombe, et al.
Hepatology Communications (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 4
Anne-Flore Legrand, Julie Lucifora, Benoît Lacombe, et al.
Hepatology Communications (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 4
Hijacking host extracellular vesicle machinery by hepatotropic viruses: current understandings and future prospects
Yu‐De Chu, M J Chen, Chau‐Ting Yeh, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Yu‐De Chu, M J Chen, Chau‐Ting Yeh, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis
Romina Salpini, Stefano D′Anna, Lorenzo Piermatteo, et al.
Journal of Viral Hepatitis (2022) Vol. 29, Iss. 12, pp. 1038-1047
Closed Access | Times Cited: 7
Romina Salpini, Stefano D′Anna, Lorenzo Piermatteo, et al.
Journal of Viral Hepatitis (2022) Vol. 29, Iss. 12, pp. 1038-1047
Closed Access | Times Cited: 7
Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxysterol derivatives in vitro
Hirofumi Ohashi, Feng Wang, Frank Stappenbeck, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Hirofumi Ohashi, Feng Wang, Frank Stappenbeck, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Current status of hepatitis delta
Μargarita Papatheodoridi, George Papatheodoridis
Current Opinion in Pharmacology (2021) Vol. 58, pp. 62-67
Closed Access | Times Cited: 9
Μargarita Papatheodoridi, George Papatheodoridis
Current Opinion in Pharmacology (2021) Vol. 58, pp. 62-67
Closed Access | Times Cited: 9
Hepatitis D infection induces IFN-β-mediated NK cell activation and TRAIL-dependent cytotoxicity
Christopher Groth, Jovana Marić, Irene Garcés Lázaro, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Christopher Groth, Jovana Marić, Irene Garcés Lázaro, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Bulevirtide als erster spezifischer Wirkstoff gegen Hepatitis-D-Virusinfektionen – Mechanismus und klinische Wirkung
Shirin Nkongolo, Julius Hollnberger, Stephan Urban
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2022) Vol. 65, Iss. 2, pp. 254-263
Open Access | Times Cited: 5
Shirin Nkongolo, Julius Hollnberger, Stephan Urban
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2022) Vol. 65, Iss. 2, pp. 254-263
Open Access | Times Cited: 5
Hepatitis delta treatment with bulevirtide in real life: a case report
Marc-Antoine Giordan, Jessica Grace BENGONE ABOGOURIN, Sarah Aherfi, et al.
International Journal of Antimicrobial Agents (2022) Vol. 59, Iss. 5, pp. 106562-106562
Closed Access | Times Cited: 5
Marc-Antoine Giordan, Jessica Grace BENGONE ABOGOURIN, Sarah Aherfi, et al.
International Journal of Antimicrobial Agents (2022) Vol. 59, Iss. 5, pp. 106562-106562
Closed Access | Times Cited: 5
Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro
Maud Michelet, Dulce Alfaiate, Brieux Chardès, et al.
JHEP Reports (2021) Vol. 4, Iss. 3, pp. 100415-100415
Open Access | Times Cited: 7
Maud Michelet, Dulce Alfaiate, Brieux Chardès, et al.
JHEP Reports (2021) Vol. 4, Iss. 3, pp. 100415-100415
Open Access | Times Cited: 7
Emerging drugs for hepatitis D
Onur Keskın, Cihan Yurdaydìn
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 2, pp. 55-66
Closed Access | Times Cited: 2
Onur Keskın, Cihan Yurdaydìn
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 2, pp. 55-66
Closed Access | Times Cited: 2
Performance of Hepatitis Delta Virus (HDV) RNA Testing for the Diagnosis of Active HDV Infection: Systematic Review and Meta-analysis
Sisi Chen, Xiangying Zhang, Ling Xu, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Sisi Chen, Xiangying Zhang, Ling Xu, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Hepatitis E Virus Infection Caused Elevation of Alanine Aminotransferase Levels in a Patient with Chronic Hepatitis B and Choledocholithiasis
Rei Hirano, Tatsuo Kanda, Masayuki Honda, et al.
Reports — Medical Cases Images and Videos (2023) Vol. 6, Iss. 4, pp. 55-55
Open Access | Times Cited: 2
Rei Hirano, Tatsuo Kanda, Masayuki Honda, et al.
Reports — Medical Cases Images and Videos (2023) Vol. 6, Iss. 4, pp. 55-55
Open Access | Times Cited: 2
Hepatitis D: advances and challenges
Zhijiang Miao, Zhenrong Xie, Li Ren, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 7, pp. 767-773
Open Access | Times Cited: 4
Zhijiang Miao, Zhenrong Xie, Li Ren, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 7, pp. 767-773
Open Access | Times Cited: 4
Immunology of hepatitis D virus infection: General concepts and present evidence
Reem Hoblos, Helenie Kefalakes
Liver International (2022) Vol. 43, Iss. S1, pp. 47-59
Open Access | Times Cited: 3
Reem Hoblos, Helenie Kefalakes
Liver International (2022) Vol. 43, Iss. S1, pp. 47-59
Open Access | Times Cited: 3
Inhibition of Cellular Factor TM6SF2 Suppresses Secretion Pathways of Hepatitis B, Hepatitis C, and Hepatitis D Viruses
Thomas Tu, Harout Ajoyan, Rifqiyah Nur Umami, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 4, pp. 970-981
Closed Access
Thomas Tu, Harout Ajoyan, Rifqiyah Nur Umami, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 4, pp. 970-981
Closed Access
An hepatitis B and D virus infection model using human pluripotent stem cell-derived hepatocytes
Huanting Chi, Bingqian Qu, Angga Prawira, et al.
EMBO Reports (2024) Vol. 25, Iss. 10, pp. 4311-4336
Open Access
Huanting Chi, Bingqian Qu, Angga Prawira, et al.
EMBO Reports (2024) Vol. 25, Iss. 10, pp. 4311-4336
Open Access
Modern aspects of anti-viral therapy for hepatitis D
A. S. Zheleznova, Kirill A. Svirin, M. Yu. Kartashov
Journal Infectology (2024) Vol. 16, Iss. 4, pp. 24-35
Open Access
A. S. Zheleznova, Kirill A. Svirin, M. Yu. Kartashov
Journal Infectology (2024) Vol. 16, Iss. 4, pp. 24-35
Open Access
Intrinsic Immune Response of HBV/HDV-Infected Cells and Corresponding Innate (Like) Immune Cell Activation
Christopher Groth, Svea Wupper, Gnimah Eva Gnouamozi, et al.
Livers (2024) Vol. 4, Iss. 4, pp. 562-593
Open Access
Christopher Groth, Svea Wupper, Gnimah Eva Gnouamozi, et al.
Livers (2024) Vol. 4, Iss. 4, pp. 562-593
Open Access
Host-Targeting Antivirals for Chronic Viral Infections of the Liver
Nicola Frericks, Mara Klöhn, Frauke Lange, et al.
Antiviral Research (2024), pp. 106062-106062
Closed Access
Nicola Frericks, Mara Klöhn, Frauke Lange, et al.
Antiviral Research (2024), pp. 106062-106062
Closed Access
Human pluripotent stem cell-derived hepatocyte-like cells for hepatitis D virus studies
Huanting Chi, Bingqian Qu, Angga Prawira, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Huanting Chi, Bingqian Qu, Angga Prawira, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis
Pavel Bogomolov, В. Т. Ивашкин, А. О. Буеверов, et al.
Terapevticheskii arkhiv (2021) Vol. 93, Iss. 11, pp. 1290-1299
Open Access | Times Cited: 3
Pavel Bogomolov, В. Т. Ивашкин, А. О. Буеверов, et al.
Terapevticheskii arkhiv (2021) Vol. 93, Iss. 11, pp. 1290-1299
Open Access | Times Cited: 3
Insrr Regulates IFN-β through Regulation of Actin Cytoskeleton Pathway in Rat Hepatocellular Carcinoma
Chunxiu Peng, Zhijian Ye, Ying Ju, et al.
Research Square (Research Square) (2023)
Open Access
Chunxiu Peng, Zhijian Ye, Ying Ju, et al.
Research Square (Research Square) (2023)
Open Access
[Delta hepatitis in Africa: epidemiological and clinical particularities].
F Fabiani, Ahmed El Bara, Cheikh Tijani Hamed, et al.
PubMed (2023) Vol. 3, Iss. 4
Closed Access
F Fabiani, Ahmed El Bara, Cheikh Tijani Hamed, et al.
PubMed (2023) Vol. 3, Iss. 4
Closed Access
